聚合物纳米粒子:用于增强癌症药物输送系统的创新和有前途的工具
1Department of Pharmaceutics, College of Pharmacy, Jazan University, Jazan, 45142, Saudi Arabia.
Current pharmaceutical design
|March 1, 2026
概括
可生物降解的聚合物纳米粒子增强癌症药物输送,改善向性和降低毒性. 进一步的研究是克服挑战和充分实现其瘤学潜力的必要条件.
科学领域:
- 瘤学和纳米医学
背景情况:
- 癌症对全球健康造成重大负担,沙特阿拉伯的发病率越来越高.
- 由基因突变驱动的多药性耐药性 (MDR) 是癌症治疗的重大临床挑战.
- 创新的药物输送系统对于提高治疗疗效至关重要.
研究的目的:
- 审查和分析聚合物纳米粒子在癌症治疗中的应用.
- 评估这些纳米颗粒在改善药物输送和克服耐药性的潜力.
- 确定纳米粒子基础癌症治疗的当前挑战和未来方向.
主要方法:
- 在知名数据库 (Web of Science,PubMed,EMBASE,ScienceDirect,Scopus) 中进行全面的文献搜索.
- 在癌症治疗中对聚合物纳米颗粒的同行评审研究的批判性分析 (体外,体内,临床).
- 排除非英语,不完整或方法上较弱的研究.
主要成果:
- 可生物降解的聚合物纳米颗粒 (例如PLGA,奇托,PCL) 改善抗癌药物输送.
- 这些纳米颗粒可以实现精确的准,减少系统性毒性,并有助于克服多种药物耐药性.
- 在所有审查的研究中观察到一致的治疗益处.
结论:
- 聚合物纳米粒子通过增强药物输送和最大限度地减少副作用,显著改善癌症治疗的前景.
- 包括生物相容性,毒性,受控释放,瘤异质性,长期安全性和监管问题在内的挑战需要进一步调查.
- 持续的研究和跨学科的合作对于最大限度地发挥纳米颗粒在瘤学的潜力至关重要.
相关概念视频
Site-Targeted Drug Delivery Systems: Polymeric Carriers
63
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
63
Modified-Release Drug Delivery Systems: Site-Targeted
51
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
51
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K


